Erlotinib in Combination With Cetuximab

Clinical trial NCT00895362 · COMPLETED

Trial details

NCT number: NCT00895362
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancers

Start date: 2009-04-01
Primary completion: 2015-07-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.